Document is current
Any future updates will be listed below
-
Authors
Sahel, José-Alain https://orcid.org/0000-0002-4831-1153
Boulanger-Scemama, Elise
Pagot, Chloé https://orcid.org/0000-0003-1827-1979
Arleo, Angelo
Galluppi, Francesco
Martel, Joseph N.
Esposti, Simona Degli
Delaux, Alexandre https://orcid.org/0000-0002-4553-9371
de Saint Aubert, Jean-Baptiste
de Montleau, Caroline https://orcid.org/0000-0003-0764-4514
Gutman, Emmanuel
Audo, Isabelle
Duebel, Jens
Picaud, Serge https://orcid.org/0000-0002-0548-5145
Dalkara, Deniz https://orcid.org/0000-0003-4112-9321
Blouin, Laure
Taiel, Magali https://orcid.org/0000-0003-1139-5178
Roska, Botond https://orcid.org/0000-0002-9559-1450
- License Information
-
More Information
Article History
Received: 23 November 2020
Accepted: 13 April 2021
First Online: 24 May 2021
Competing interests
: F.G., L.B. and M.T. are employees of GenSight Biologics. B.R. is the Chair of the Scientific Advisory Board of GenSight Biologics and is a board member of and has financial interest in Arctos Medical AG. J.-A.S. has personal financial interests in GenSight Biologics, Pixium Vision, SparingVision, Prophesee, Tilak, VegaVect, NewSight and Chronolife. E.B.-S. is a consultant for GenSight Biologics. D.D. was a consultant for GenSight Biologics, is a cofounder and acting Chief Strategy Officer of Gamut Tx. D.D. is an inventor on a patent of adeno-associated virus virions with variant capsid and methods of use thereof with royalties paid to Adverum (WO2012145601 A2). S.P. owns shares in, received consultant fees from and has filed a patent (WO 2017/187272) licensed to GenSight Biologics. S.P. has financial interests in Pixium Vision, Gamut, Iconeus, Chronolife, Neurallys and Prophesee. I.A. is a consultant for Novartis, Biogen and SparingVision and a cofounder of Gamut Tx. The other authors declare no competing interests.
